Align Technology | Rövid Lejáratú Kötelezettségek



Current Liabilities változás Dátum
3M USD 11.26B 135M 2024-12
Align Technology USD 2.04B 25.59M 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Bruker USD 1.28B 37.5M 2024-12
Cardinal Health USD 35.22B 545M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
CVS Health USD 84.61B 18M 2024-12
Danaher USD 6.8B 541M 2024-12
Dentsply International USD 1.59B 47M 2024-12
Dexcom USD 2.93B 1.2B 2024-12
Henry Schein USD 2.8B 126M 2024-12
Idexx Laboratories USD 1.07B 58.69M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
Masimo USD 617.7M 19.9M 2024-12
McKesson USD 58.56B 209M 2024-12
Mettler Toledo International USD 1.17B 16.77M 2024-12
Patterson Companies USD 1.31B 39.02M 2025-01
Revvity USD 653.1M 34.84M 2024-12
Solventum Corp 2.7B 201M 2024-12
Stryker USD 7.62B 53M 2024-12
Teleflex USD 649.36M 30.61M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
Veeva Systems USD 1.4B 541.4M 2025-01
Walgreens Boots Alliance USD 27.45B 500M 2024-11
Waters USD 789.76M 26.28M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12
Zoetis USD 3.41B 1.71B 2024-12



Align Technology Rövid Lejáratú Kötelezettségek - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.